Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 SALES VOLUME DATA
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER'S FIVE FORCES MODEL
6 INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYSIS AND RECOMMENDATIONS
7 INTELLECTUAL PROPERTY (IP) PORTFOLIO
7.1 PATENT QUALITY AND STRENGTH
7.2 PATENT FAMILIES
7.3 LICENSING AND COLLABORATIONS
7.4 COMPETITIVE LANDSCAPE
7.5 IP STRATEGY AND MANAGEMENT
7.6 OTHER
8 COST ANALYSIS BREAKDOWN
9 TECHNOLOGY ROADMAP
10 INNOVATION TRACKER AND STRATEGIC ANALYSIS
10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
10.1.1 JOINT VENTURES
10.1.2 MERGERS AND ACQUISITIONS
10.1.3 LICENSING AND PARTNERSHIP
10.1.4 TECHNOLOGY COLLABORATIONS
10.1.5 STRATEGIC DIVESTMENTS
10.2 NUMBER OF PRODUCTS IN DEVELOPMENT
10.3 STAGE OF DEVELOPMENT
10.4 TIMELINES AND MILESTONES
10.5 INNOVATION STRATEGIES AND METHODOLOGIES
10.6 RISK ASSESSMENT AND MITIGATION
10.7 FUTURE OUTLOOK
11 REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.2.1 CLASS I
11.2.2 CLASS II
11.2.3 CLASS III
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
11.6 REGULATORY CHALLENGES AND STRATEGIES
12 REIMBURSEMENT FRAMEWORK
13 OPPUTUNITY MAP ANALYSIS
14 VALUE CHAIN ANALYSIS
15 HEALTHCARE ECONOMY
15.1 HEALTHCARE EXPENDITURE
15.2 CAPITAL EXPENDITURE
15.3 CAPEX TRENDS
15.4 CAPEX ALLOCATION
15.5 FUNDING SOURCES
15.6 INDUSTRY BENCHMARKS
15.7 GDP RATION IN OVERALL GDP
15.8 HEALTHCARE SYSTEM STRUCTURE
15.9 GOVERNMENT POLICIES
15.1 ECONOMIC DEVELOPMENT
16 GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, BY OFFERING
16.1 OVERVIEW
16.2 HARDWARE
16.2.1 PROCESSORS
16.2.1.1. MICRO-PROCESSING UNIT (MPU)
16.2.1.2. GRAPHICS PROCESSING UNIT (GPU)
16.2.1.3. FIELD-PROGRAMMABLE GATE ARRAY (FGPA)
16.2.1.4. OTHERS
16.2.2 MEMORY
16.2.3 NETWORK
16.3 SOFTWARE
16.3.1 BY TYPE
16.3.1.1. INTEGRATED
16.3.1.2. STANDLAONE
16.3.2 BY OPERATING SYSTEN
16.3.2.1. IOS
16.3.2.2. WINDOWS
16.3.2.3. LINUX
16.3.2.4. OTHERS
16.3.3 BY MODALITY
16.3.3.1. PLATFORMS BASED
16.3.3.1.1. APPLICATION PROGRAM INTERFACE (API)
16.3.3.1.2. MACHINE LEARNING FRAMEWORK
16.3.3.2. SOLUTIONS
16.4 SERVICES
17 SERVICES GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, BY TECHNOLOGY
17.1 OVERVIEW
17.2 MACHINE LEARNING
17.2.1 DEEP LEARNING
17.2.1.1. CONVOLUTIONAL NEURAL NETWORK (CNN)
17.2.1.2. RECURRENT NEURAL NETWORK (RNN)
17.2.1.3. GENERATIVE ADVERSARIAL NETWORKS (GAN)
17.2.2 SUPERVISED LEARNING
17.2.3 REINFORCEMENT LEARNING
17.2.4 UNSUPERVISED LEARNING
17.3 NATURAL LANGUAGE PROCESSING (NLP)
17.3.1 OCR
17.3.2 PATTERN & IMAGE RECOGNITION
17.3.3 AUTO CODING
17.3.4 CLASSIFICATION & CATEGORIZATION
17.3.5 TEXT ANALYTICS
17.3.6 SPEECH ANALYTICS
17.4 CONTEXT-AWARENESS COMPUTING
17.5 COMPUTER VISION
17.6 OTHERS
18 GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, BY ENTERPRISE SIZE
18.1 OVERVIEW
18.2 SMALL & MEDIUM SIZE ENTERPRISE
18.2.1 BY DEPLOYMENT MODE
18.2.1.1. ON-PREMISE
18.2.1.2. WEB/CLOUD BASED
18.3 LARGE SIZE ENTERPRISE
18.3.1 BY DEPLOYMENT MODE
18.3.1.1. ON-PREMISE
18.3.1.2. WEB/CLOUD BASED
19 GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET , BY DEPLOYMENT TYPE
19.1 OVERVIEW
19.2 ON-PREMISE
19.3 WEB/CLOUD BASED
20 GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET , BY APPLICATION
20.1 OVERVIEW
20.2 DIAGNOSTIC SYSTEMS
20.2.1 MAGNETIC RESONANCE IMAGING (MRI)
20.2.1.1. OPEN MRI SYSTEMS
20.2.1.2. CLOSED MRI SYSTEMS
20.2.2 X-RAY
20.2.2.1. STATIONARY
20.2.2.2. PORTABLE
20.2.3 COMPUTED TOMOGRAPHY (CT)
20.2.3.1. HIGH-SLICE
20.2.3.2. MID-SLICE
20.2.3.3. LOW-SLICE
20.2.4 ULTRASOUND
20.2.4.1. COLOR ULTRASOUND DEVICES
20.2.4.2. B/W ULTRASOUND DEVICES
20.2.5 MOLECULAR IMAGING
20.2.5.1. SPECT SYSTEMS/SCANNERS
20.2.5.1.1. HYBRID SPECT
20.2.5.1.2. STANDALONE SPECT
20.2.5.2. PET SYSTEMS/SCANNERS
20.2.6 OTHERS
20.3 INTERVENTIONAL SYSTEMS
21 GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET , BY CLINICAL APPLICATION
21.1 OVERVIEW
21.2 CARDIOLOGY
21.3 ONCOLOGY
21.4 BREAST (MAMMOGRAPHY)
21.5 GYNECOLOGY
21.6 UROLOGY
21.7 NEUROLOGY
21.8 MUSCULOSKELETAL
21.9 LUNGS (RESPIRATORY SYSTEM)
21.1 ORTHOPEDICS
21.11 DENTAL
21.12 PELVIC AND ABDOMINAL
21.13 OTHERS
22 GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, BY END USER
22.1 OVERVIEW
22.2 HOSPITALS
22.3 SPECIALTY CLINICS
22.4 DIAGNOSTIC IMAGING CENTERS
22.5 AMBULATORY SURGICAL CENTERS
22.6 ACADEMIC & RESEARCH INSTITUTES
22.7 OTHERS
23 GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, COMPANY LANDSCAPE
23.1 COMPANY SHARE ANALYSIS: GLOBAL
23.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
23.3 COMPANY SHARE ANALYSIS: EUROPE
23.4 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
23.5 MERGERS & ACQUISITIONS
23.6 NEW PRODUCT DEVELOPMENT & APPROVALS
23.7 EXPANSIONS
23.8 REGULATORY CHANGES
23.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
24 GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, SWOT AND DBMR ANALYSIS
25 GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, BY REGION
GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
25.1 NORTH AMERICA
25.1.1 U.S.
25.1.2 CANADA
25.1.3 MEXICO
25.2 EUROPE
25.2.1 GERMANY
25.2.2 FRANCE
25.2.3 U.K.
25.2.4 HUNGARY
25.2.5 LITHUANIA
25.2.6 AUSTRIA
25.2.7 IRELAND
25.2.8 NORWAY
25.2.9 POLAND
25.2.10 ITALY
25.2.11 SPAIN
25.2.12 RUSSIA
25.2.13 TURKEY
25.2.14 NETHERLANDS
25.2.15 SWITZERLAND
25.2.16 REST OF EUROPE
25.3 ASIA-PACIFIC
25.3.1 JAPAN
25.3.2 CHINA
25.3.3 SOUTH KOREA
25.3.4 INDIA
25.3.5 AUSTRALIA
25.3.6 SINGAPORE
25.3.7 THAILAND
25.3.8 MALAYSIA
25.3.9 INDONESIA
25.3.10 PHILIPPINES
25.3.11 VIETNAM
25.3.12 REST OF ASIA-PACIFIC
25.4 SOUTH AMERICA
25.4.1 BRAZIL
25.4.2 ARGENTINA
25.4.3 PERU
25.4.4 REST OF SOUTH AMERICA
25.5 MIDDLE EAST AND AFRICA
25.5.1 SOUTH AFRICA
25.5.2 GLOBAL
25.5.3 UAE
25.5.4 EGYPT
25.5.5 KUWAIT
25.5.6 ISRAEL
25.5.7 REST OF MIDDLE EAST AND AFRICA
25.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
26 GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, COMPANY PROFILE
26.1 BENEVOLENTAI
26.1.1 COMPANY OVERVIEW
26.1.2 REVENUE ANALYSIS
26.1.3 GEOGRAPHIC PRESENCE
26.1.4 PRODUCT PORTFOLIO
26.1.5 RECENT DEVELOPMENTS
26.2 CUREMETRIX, INC.
26.2.1 COMPANY OVERVIEW
26.2.2 REVENUE ANALYSIS
26.2.3 GEOGRAPHIC PRESENCE
26.2.4 PRODUCT PORTFOLIO
26.2.5 RECENT DEVELOPMENTS
26.3 HEARTVISTA INC
26.3.1 COMPANY OVERVIEW
26.3.2 REVENUE ANALYSIS
26.3.3 GEOGRAPHIC PRESENCE
26.3.4 PRODUCT PORTFOLIO
26.3.5 RECENT DEVELOPMENTS
26.4 ENVISIONIT DEEP AI (PTY) LTD
26.4.1 COMPANY OVERVIEW
26.4.2 REVENUE ANALYSIS
26.4.3 GEOGRAPHIC PRESENCE
26.4.4 PRODUCT PORTFOLIO
26.4.5 RECENT DEVELOPMENTS
26.5 MERATIVE
26.5.1 COMPANY OVERVIEW
26.5.2 REVENUE ANALYSIS
26.5.3 GEOGRAPHIC PRESENCE
26.5.4 PRODUCT PORTFOLIO
26.5.5 RECENT DEVELOPMENTS
26.6 LUNIT INC.
26.6.1 COMPANY OVERVIEW
26.6.2 REVENUE ANALYSIS
26.6.3 GEOGRAPHIC PRESENCE
26.6.4 PRODUCT PORTFOLIO
26.6.5 RECENT DEVELOPMENTS
26.7 SIEMENS HEALTHCARE PRIVATE LIMITED
26.7.1 COMPANY OVERVIEW
26.7.2 REVENUE ANALYSIS
26.7.3 GEOGRAPHIC PRESENCE
26.7.4 PRODUCT PORTFOLIO
26.7.5 RECENT DEVELOPMENTS
26.8 KONINKLIJKE PHILIPS N.V.
26.8.1 COMPANY OVERVIEW
26.8.2 REVENUE ANALYSIS
26.8.3 GEOGRAPHIC PRESENCE
26.8.4 PRODUCT PORTFOLIO
26.8.5 RECENT DEVELOPMENTS
26.9 GE HEALTHCARE
26.9.1 COMPANY OVERVIEW
26.9.2 REVENUE ANALYSIS
26.9.3 GEOGRAPHIC PRESENCE
26.9.4 PRODUCT PORTFOLIO
26.9.5 RECENT DEVELOPMENTS
26.1 ALIVECOR, INC.
26.10.1 COMPANY OVERVIEW
26.10.2 REVENUE ANALYSIS
26.10.3 GEOGRAPHIC PRESENCE
26.10.4 PRODUCT PORTFOLIO
26.10.5 RECENT DEVELOPMENTS
26.11 INTEL CORPORATION
26.11.1 COMPANY OVERVIEW
26.11.2 REVENUE ANALYSIS
26.11.3 GEOGRAPHIC PRESENCE
26.11.4 PRODUCT PORTFOLIO
26.11.5 RECENT DEVELOPMENTS
26.12 ECHONOUS INC.
26.12.1 COMPANY OVERVIEW
26.12.2 REVENUE ANALYSIS
26.12.3 GEOGRAPHIC PRESENCE
26.12.4 PRODUCT PORTFOLIO
26.12.5 RECENT DEVELOPMENTS
26.13 ENLITIC, INC.
26.13.1 COMPANY OVERVIEW
26.13.2 REVENUE ANALYSIS
26.13.3 GEOGRAPHIC PRESENCE
26.13.4 PRODUCT PORTFOLIO
26.13.5 RECENT DEVELOPMENTS
26.14 OWKIN, INC
26.14.1 COMPANY OVERVIEW
26.14.2 REVENUE ANALYSIS
26.14.3 GEOGRAPHIC PRESENCE
26.14.4 PRODUCT PORTFOLIO
26.14.5 RECENT DEVELOPMENTS
26.15 GOOGLE HEALTH
26.15.1 COMPANY OVERVIEW
26.15.2 REVENUE ANALYSIS
26.15.3 GEOGRAPHIC PRESENCE
26.15.4 PRODUCT PORTFOLIO
26.15.5 RECENT DEVELOPMENTS
26.16 BUTTERFLY NETWORK, INC
26.16.1 COMPANY OVERVIEW
26.16.2 REVENUE ANALYSIS
26.16.3 GEOGRAPHIC PRESENCE
26.16.4 PRODUCT PORTFOLIO
26.16.5 RECENT DEVELOPMENTS
26.17 ACCRAD TECHNOLOGIES, INC.
26.17.1 COMPANY OVERVIEW
26.17.2 REVENUE ANALYSIS
26.17.3 GEOGRAPHIC PRESENCE
26.17.4 PRODUCT PORTFOLIO
26.17.5 RECENT DEVELOPMENTS
26.18 INNOHEALTH TECHNOLOGIES
26.18.1 COMPANY OVERVIEW
26.18.2 REVENUE ANALYSIS
26.18.3 GEOGRAPHIC PRESENCE
26.18.4 PRODUCT PORTFOLIO
26.18.5 RECENT DEVELOPMENTS
26.19 HEARX IP (PTY) LTD.
26.19.1 COMPANY OVERVIEW
26.19.2 REVENUE ANALYSIS
26.19.3 GEOGRAPHIC PRESENCE
26.19.4 PRODUCT PORTFOLIO
26.19.5 RECENT DEVELOPMENTS
26.2 CARL ZEISS MICROSCOPY SOFTWARE CENTER ROSTOCK GMBH
26.20.1 COMPANY OVERVIEW
26.20.2 REVENUE ANALYSIS
26.20.3 GEOGRAPHIC PRESENCE
26.20.4 PRODUCT PORTFOLIO
26.20.5 RECENT DEVELOPMENTS
26.21 FUJIFILM CORPORATION
26.21.1 COMPANY OVERVIEW
26.21.2 REVENUE ANALYSIS
26.21.3 GEOGRAPHIC PRESENCE
26.21.4 PRODUCT PORTFOLIO
26.21.5 RECENT DEVELOPMENTS
26.22 DR CADX
26.22.1 COMPANY OVERVIEW
26.22.2 REVENUE ANALYSIS
26.22.3 GEOGRAPHIC PRESENCE
26.22.4 PRODUCT PORTFOLIO
26.22.5 RECENT DEVELOPMENTS
26.23 INTIXEL
26.23.1 COMPANY OVERVIEW
26.23.2 REVENUE ANALYSIS
26.23.3 GEOGRAPHIC PRESENCE
26.23.4 PRODUCT PORTFOLIO
26.23.5 RECENT DEVELOPMENTS
26.24 ALGORIZMIH HEALTH
26.24.1 COMPANY OVERVIEW
26.24.2 REVENUE ANALYSIS
26.24.3 GEOGRAPHIC PRESENCE
26.24.4 PRODUCT PORTFOLIO
26.24.5 RECENT DEVELOPMENTS
26.25 DELFT IMAGING
26.25.1 COMPANY OVERVIEW
26.25.2 REVENUE ANALYSIS
26.25.3 GEOGRAPHIC PRESENCE
26.25.4 PRODUCT PORTFOLIO
26.25.5 RECENT DEVELOPMENTS
26.26 QURE.AI TECHNOLOGIES PRIVATE LIMITED
26.26.1 COMPANY OVERVIEW
26.26.2 REVENUE ANALYSIS
26.26.3 GEOGRAPHIC PRESENCE
26.26.4 PRODUCT PORTFOLIO
26.26.5 RECENT DEVELOPMENTS
26.27 AIDOC
26.27.1 COMPANY OVERVIEW
26.27.2 REVENUE ANALYSIS
26.27.3 GEOGRAPHIC PRESENCE
26.27.4 PRODUCT PORTFOLIO
26.27.5 RECENT DEVELOPMENTS
26.28 NANO-X IMAGING LTD.
26.28.1 COMPANY OVERVIEW
26.28.2 REVENUE ANALYSIS
26.28.3 GEOGRAPHIC PRESENCE
26.28.4 PRODUCT PORTFOLIO
26.28.5 RECENT DEVELOPMENTS
26.29 INTERNATIONAL BUSINESS MACHINES CORPORATION
26.29.1 COMPANY OVERVIEW
26.29.2 REVENUE ANALYSIS
26.29.3 GEOGRAPHIC PRESENCE
26.29.4 PRODUCT PORTFOLIO
26.29.5 RECENT DEVELOPMENTS
27 RELATED REPORTS
28 CONCLUSION
29 QUESTIONNAIRE
30 ABOUT DATA BRIDGE MARKET RESEARCH
